News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
18,813 Results
Type
Article (489)
Company Profile (7)
Press Release (18317)
Section
Business (4951)
Career Advice (28)
Deals (972)
Drug Development (2319)
Employer Resources (2)
FDA (639)
Job Trends (631)
News (9115)
Policy (937)
Tag
2027 Pharm Country Standard (1)
Academia (44)
Academic (1)
Accelerated approval (1)
Alliances (1070)
ALS (1)
Alzheimer's disease (17)
Antibody-drug conjugate (ADC) (23)
Approvals (704)
Artificial intelligence (2)
Autoimmune disease (8)
Bankruptcy (7)
Best Places to Work (632)
Biosimilars (10)
Biotechnology (2)
Bladder cancer (7)
Brain cancer (1)
Breast cancer (36)
Cancer (275)
Cardiovascular disease (9)
Career advice (23)
CAR-T (10)
Cell therapy (24)
Cervical cancer (2)
Clinical research (2214)
Collaboration (43)
Compensation (13)
Complete response letters (1)
COVID-19 (34)
CRISPR (2)
C-suite (9)
Cystic fibrosis (4)
Data (281)
Depression (3)
Diabetes (20)
Diagnostics (158)
Digital health (1)
Drug discovery (4)
Drug pricing (4)
Duchenne muscular dystrophy (4)
Earnings (2488)
Editorial (2)
Employer branding (2)
Employer resources (2)
Events (3095)
Executive appointments (16)
FDA (795)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (18)
Gene editing (3)
Gene therapy (21)
GLP-1 (42)
Government (157)
Guidances (24)
Healthcare (644)
HIV (2)
Immunology and inflammation (4)
Immuno-oncology (2)
Indications (10)
Infectious disease (34)
Inflammatory bowel disease (5)
Intellectual property (10)
Interviews (2)
IPO (486)
Job creations (49)
Job search strategy (22)
JPM (2)
Layoffs (8)
Legal (150)
Liver cancer (2)
Longevity (2)
Lung cancer (69)
Lymphoma (43)
Manufacturing (28)
MASH (3)
Medical device (483)
Medtech (486)
Mergers & acquisitions (524)
Metabolic disorders (42)
Neurodegenerative disease (5)
Neuropsychiatric disorders (1)
Neuroscience (73)
NextGen: Class of 2026 (185)
Non-profit (43)
Now hiring (5)
Obesity (18)
Opinion (3)
Ovarian cancer (11)
Pain (4)
Pancreatic cancer (4)
Parkinson's disease (40)
Patents (11)
Patient recruitment (12)
People (1337)
Pharmaceutical (2)
Phase 1 (573)
Phase 2 (972)
Phase 3 (907)
Pipeline (213)
Policy (2)
Postmarket research (46)
Preclinical (158)
Press Release (8)
Prostate cancer (8)
Radiopharmaceuticals (9)
Rare diseases (28)
Real estate (127)
Recruiting (1)
Regulatory (827)
Research institute (35)
Resumes & cover letters (5)
Schizophrenia (5)
Series A (2)
Series B (5)
Service/supplier (1)
Sickle cell disease (5)
Startups (68)
Stomach cancer (1)
Supply chain (2)
Tariffs (1)
The Weekly (1)
Vaccines (23)
Weight loss (9)
Date
Last 7 days (15)
Last 30 days (65)
Last 365 days (996)
2026 (94)
2025 (1013)
2024 (1207)
2023 (1399)
2022 (2051)
2021 (1945)
2020 (1816)
2019 (1406)
2018 (984)
2017 (772)
2016 (726)
2015 (813)
2014 (564)
2013 (541)
2012 (565)
2011 (563)
2010 (402)
Location
Africa (18)
Arizona (4)
Asia (2291)
Australia (239)
California (299)
Canada (141)
China (121)
Colorado (2)
Connecticut (20)
Delaware (16)
Europe (2319)
Florida (42)
Georgia (1)
Idaho (2)
Illinois (128)
India (1)
Indiana (4)
Japan (17)
Kansas (4)
Kentucky (2)
Maryland (55)
Massachusetts (137)
Michigan (2)
Minnesota (27)
Nevada (2)
New Jersey (148)
New York (79)
North Carolina (23)
Northern California (127)
Ohio (3)
Oregon (2)
Pennsylvania (136)
Rhode Island (2)
South America (18)
South Carolina (1)
Southern California (145)
Tennessee (12)
Texas (16)
United States (1156)
Utah (1)
Virginia (2)
Washington D.C. (1)
Washington State (13)
Wisconsin (1)
18,813 Results for "gc aesthetics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GC Therapeutics Appoints Kate Haviland as Board Chair and Provides Corporate Update
January 9, 2026
·
6 min read
Press Releases
GC Biopharma Secures IND Approval for Phase 1 Clinical Trial of COVID-19 mRNA Vaccine in Korea
December 23, 2025
·
3 min read
Press Releases
GC Biopharma’s Varicella Vaccine Strain ‘MAV/06' Listed in WHO Position Paper
December 2, 2025
·
3 min read
Press Releases
GC Biopharma Ships First Doses of World’s First Recombinant Anthrax Vaccine, ‘BARYTHRAX inj.’
December 8, 2025
·
3 min read
Press Releases
GC Genome Publishes Blood-Based Colorectal Cancer Screening Study in the American Journal of Gastroenterology
November 27, 2025
·
2 min read
Press Releases
Immunofoco Presents Phase I/IIa Data of IMC002 at ASCO GI 2026, Highlighting a Durable Complete Response Beyond One Year and a 66.7% ORR in Advanced GC/GEJ
January 13, 2026
·
5 min read
Press Releases
GC Biopharma Secures CMO Rights for Shingles Vaccine from Curevo Vaccine
October 13, 2025
·
3 min read
Press Releases
Allergan Aesthetics Unveils New Data Across Facial Injectables On-Market and Emerging Portfolio at IMCAS 2026 Showcasing Enduring Strength in Advancing Aesthetics Medicine
January 29, 2026
·
18 min read
Press Releases
GC Biopharma’s Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in ‘Vaccine’
November 3, 2025
·
4 min read
New Independent Clinical Study Showcases Safety and Efficacy of GC Aesthetics’ PERLE Breast Implant
GC Aesthetics® (GCA), a privately-held medical technology company providing aesthetic and reconstruction solutions for global healthcare markets, is proud to announce that its breast implant, PERLE™, has been featured in a recent independent peer-reviewed article published in the Aesthetic Surgery Journal Open Forum.
January 26, 2024
·
2 min read
1 of 1,882
Next
